Agile Therapeutics reports plans to price initial public stock sale

RBC Capital Markets, William Blair are the joint bookrunning managers

By Devika Patel

Knoxville, Tenn., March 17 - Agile Therapeutics, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission.

RBC Capital Markets and William Blair are the joint bookrunning managers. Cantor Fitzgerald & Co. and Janney Montgomery Scott LLC are the co-managers.

Proceeds will be used for clinical trials, equipment validation and expansion of Corium's manufacturing capabilities, development of the company's product candidate pipeline, making scheduled principal and interest payments on the company's term loan with Oxford Finance, LLC, working capital and general corporate purposes.

The women's health specialty pharmaceutical company is based in Princeton, N.J. The company intends to list its common stock on the Nasdaq under the symbol "AGRX."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.